#Global

Traditionally hep C transmits sexually mostly among HIV-positive men who have sex with men.

Researchers followed a group of teenagers over time and found that their rate of non-alcoholic fatty liver disease rose in young adulthood.

This finding is from a program that sought to provide blanket treatment to Iceland’s hep C population.

Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.

Researchers believe that hepatitis C is spreading through sex from the HIV-positive population to those who don’t have HIV.

A European study of nearly 19,000 people with HIV also found that curing hep C was not associated with heart disease or non-AIDS cancer.

Nearly all those who have completed follow-up in an ongoing Italian study have been cured.

HIV-positive men who have sex with men in Western nations historically have a significant risk of contracting hepatitis C through sex.

In particular, having a high hep B viral load increases the risk of women with HIV transmitting the latter virus to their newborns.

This finding stresses the need to reduce the risk of sexual transmission of hep C among HIV-positive men who have sex with men.

A recent study tested the effectiveness and tolerability of Technivie (ombitasvir/paritaprevir/ritonavir) among those over 65.

Doctors are finding ways to diagnose and treat this difficult-to-reach demographic.

HIV, anti-vaxxers, dengue fever and weak primary health care make the World Health Organization’s list of priorities.

Researchers compared direct-acting-antiviral treatment outcomes between those with and without a history of liver cancer.

In some non–U.S. nations, health care providers can prescribe medical-grade heroin and supervise patients as they take it.

A recent study of people in British Columbia found, however, that people who inject drugs had lower cure rates.